Multiple Myeloma

Myeloma is a type of bone marrow cancer. Bone marrow is the spongy tissue in the centre of some bones that produces the body’s blood cells. It is usually called multiple myeloma because the cancer often affects several areas of the body, such as the spine, skull, pelvis, and ribs.

Showing all 12 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price
BCMA
Antibody-drug conjugate (ADC)
Blenrep®
50 mg/mL
2 mg
tba
tba
649,00 
view product
Max:
Min: 10
Step: 1
CD38
Monoclonal Antibody
Darzalex®
20 mg/mL
2 mg
-80°C
11/2018
543,00 
view product
Max: 4
Min: 1
Step: 1
CD38
Monoclonal Antibody
Darzalex®
20 mg/mL
2 mg
-80°C
05/2019
362,00 
view product
Max: 10
Min: 1
Step: 1
CD38
Monoclonal Antibody
Darzalex®
20 mg/mL
4 mg
-80°C
11/2023
500,00 
view product
Max: 10
Min: 1
Step: 1
CD38
Monoclonal Antibody
Darzalex®
20 mg/mL
2 mg
-80°C
01/2018
482,00 
view product
Max: 10
Min: 1
Step: 1
CD38
Monoclonal Antibody
Darzalex®
20 mg/mL
3 mg
-80°C
04/2018
642,00 
view product
Max: 10
Min: 1
Step: 1
CD38
Monoclonal Antibody
Darzalex®
20 mg/mL
2 mg
-80°C
09/2019
482,00 
view product
Max: 10
Min: 1
Step: 1
CD38
Monoclonal Antibody
Darzalex®
20 mg/mL
2 mg
-80°C
01/2021
362,00 
view product
Max: 10
Min: 1
Step: 1
CD38
Monoclonal Antibody
Darzalex®
20 mg/mL
2 mg
-80°C
07/2023
362,00 
view product
Max: 10
Min: 1
Step: 1
SLAMF7
Monoclonal Antibody
Empliciti®
25 mg/mL
6 mg
-80 °C
09/2022
339,00 
view product
Max: 10
Min: 1
Step: 1
SLAMF7
Monoclonal Antibody
Empliciti®
25 mg/mL
6 mg
-80°C
02/2024
339,00 
view product
Max: 10
Min: 1
Step: 1
CD38
Monoclonal Antibody
Sarclisa®
20 mg/mL
2 mg
tba
tba
247,00 
view product
Max:
Min: 10
Step: 1

Not looking for Multiple Myeloma?

Search our therapeutic molecules product database

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.

we are recruiting